{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34257639", "DateCompleted": {"Year": "2022", "Month": "01", "Day": "18"}, "DateRevised": {"Year": "2022", "Month": "01", "Day": "18"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "06", "Day": "26"}], "Language": ["eng"], "ELocationID": ["5566890", "10.1155/2021/5566890"], "Journal": {"ISSN": "1687-5443", "JournalIssue": {"Volume": "2021", "PubDate": {"Year": "2021"}}, "Title": "Neural plasticity", "ISOAbbreviation": "Neural Plast"}, "ArticleTitle": "The Anticonvulsant Effect of Hydroethanolic Leaf Extract of <i>Calotropis procera</i> (Ait) R. Br. (Apocynaceae).", "Pagination": {"StartPage": "5566890", "MedlinePgn": "5566890"}, "Abstract": {"AbstractText": ["A number of currently used drugs have been obtained from medicinal plants which are a major source of drugs. These drugs are either used in their pure form or modified to a semisynthetic drug. Drug discovery through natural product research has been fruitful over the years. Traditionally, <i>Calotropis procera</i> is used extensively in the management of epilepsy. This study is conducted to explore the anticonvulsant effect of a hydroethanolic leaf extract of <i>Calotropis procera</i> (CPE) in murine models. This effect was evaluated using picrotoxin-induced convulsions, strychnine-induced convulsions, and isoniazid- and pilocarpine-induced <i>status epilepticus</i> in mice of both sexes. The results showed that CPE (100-300\u2009mg/kg) exhibited an anticonvulsant effect against strychnine-induced clonic seizures by significantly reducing the duration (<i>p</i> = 0.0068) and frequency (<i>p</i> = 0.0016) of convulsions. The extract (100-300\u2009mg/kg) caused a profound dose-dependent delay in the onset of clonic convulsions induced by picrotoxin (<i>p</i> < 0.0001) and tonic convulsions (<i>p</i> < 0.0001) in mice. The duration of convulsions was reduced significantly also for both clonic and tonic (<i>p</i> < 0.0001) seizures as well. CPE (100-300\u2009mg/kg), showed a profound anticonvulsant effect and reduced mortality in the pilocarpine-induced convulsions. ED<sub>50</sub> (~0.1007) determined demonstrated that the extract was less potent than diazepam in reducing the duration and onset of convulsions but had comparable efficacies. Flumazenil-a GABA<sub>A</sub> receptor antagonist-did not reverse the onset or duration of convulsions produced by the extract in the picrotoxin-induced seizure model. In isoniazid-induced seizure, CPE (300\u2009mg\u2009kg<sup>1</sup>, <i>p.o.</i>) significantly (<i>p</i> < 0.001) delayed the onset of seizure in mice and prolonged latency to death in animals. Overall, the hydroethanolic leaf extract of <i>Calotropis procera</i> possesses anticonvulsant properties."], "CopyrightInformation": "Copyright \u00a9 2021 Ernest Obese et al."}, "AuthorList": [{"Identifier": ["0000-0001-6903-7774"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy and Pharmaceutical Sciences, College of Health and Allied Sciences, University of Cape Coast, Cape Coast, Ghana."}], "LastName": "Obese", "ForeName": "Ernest", "Initials": "E"}, {"Identifier": ["0000-0002-7566-5387"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy and Pharmaceutical Sciences, College of Health and Allied Sciences, University of Cape Coast, Cape Coast, Ghana."}], "LastName": "Biney", "ForeName": "Robert Peter", "Initials": "RP"}, {"Identifier": ["0000-0002-6830-0283"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy and Pharmaceutical Sciences, College of Health and Allied Sciences, University of Cape Coast, Cape Coast, Ghana."}], "LastName": "Henneh", "ForeName": "Isaac Tabiri", "Initials": "IT"}, {"Identifier": ["0000-0002-6254-6397"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy and Pharmaceutical Sciences, College of Health and Allied Sciences, University of Cape Coast, Cape Coast, Ghana."}], "LastName": "Adakudugu", "ForeName": "Emmanuel Awintiig", "Initials": "EA"}, {"Identifier": ["0000-0001-7086-9332"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy and Pharmaceutical Sciences, College of Health and Allied Sciences, University of Cape Coast, Cape Coast, Ghana."}], "LastName": "Anokwah", "ForeName": "Daniel", "Initials": "D"}, {"Identifier": ["0000-0003-2204-8059"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomedical Sciences, School of Allied Health Sciences, College of Health and Allied Sciences, University of Cape Coast, Cape Coast, Ghana."}], "LastName": "Agyemang", "ForeName": "Lovia Serwaa", "Initials": "LS"}, {"Identifier": ["0000-0002-2182-5736"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences, University of Allied Health Sciences, Ho, Ghana."}], "LastName": "Woode", "ForeName": "Eric", "Initials": "E"}, {"Identifier": ["0000-0002-8317-9602"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy and Pharmaceutical Sciences, College of Health and Allied Sciences, University of Cape Coast, Cape Coast, Ghana."}], "LastName": "Ameyaw", "ForeName": "Elvis Ofori", "Initials": "EO"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Neural Plast", "NlmUniqueID": "100883417", "ISSNLinking": "1687-5443"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anticonvulsants"}, {"RegistryNumber": "0", "NameOfSubstance": "Convulsants"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, GABA-A"}, {"RegistryNumber": "0", "NameOfSubstance": "Solvents"}, {"RegistryNumber": "01MI4Q9DI3", "NameOfSubstance": "Pilocarpine"}, {"RegistryNumber": "059QF0KO0R", "NameOfSubstance": "Water"}, {"RegistryNumber": "124-87-8", "NameOfSubstance": "Picrotoxin"}, {"RegistryNumber": "3K9958V90M", "NameOfSubstance": "Ethanol"}, {"RegistryNumber": "40P7XK9392", "NameOfSubstance": "Flumazenil"}, {"RegistryNumber": "H9Y79VD43J", "NameOfSubstance": "Strychnine"}, {"RegistryNumber": "Q3JTX2Q7TU", "NameOfSubstance": "Diazepam"}, {"RegistryNumber": "V83O1VOZ8L", "NameOfSubstance": "Isoniazid"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["isolation & purification", "therapeutic use"], "DescriptorName": "Anticonvulsants"}, {"QualifierName": ["chemistry"], "DescriptorName": "Calotropis"}, {"QualifierName": [], "DescriptorName": "Chromatography, High Pressure Liquid"}, {"QualifierName": ["toxicity"], "DescriptorName": "Convulsants"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Diazepam"}, {"QualifierName": [], "DescriptorName": "Drug Evaluation, Preclinical"}, {"QualifierName": [], "DescriptorName": "Ethanol"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Flumazenil"}, {"QualifierName": ["toxicity"], "DescriptorName": "Isoniazid"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred ICR"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["toxicity"], "DescriptorName": "Picrotoxin"}, {"QualifierName": ["toxicity"], "DescriptorName": "Pilocarpine"}, {"QualifierName": ["isolation & purification", "therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plant Leaves"}, {"QualifierName": ["physiology"], "DescriptorName": "Receptors, GABA-A"}, {"QualifierName": ["chemically induced", "drug therapy"], "DescriptorName": "Seizures"}, {"QualifierName": [], "DescriptorName": "Solvents"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Status Epilepticus"}, {"QualifierName": ["toxicity"], "DescriptorName": "Strychnine"}, {"QualifierName": [], "DescriptorName": "Water"}], "CoiStatement": "The authors declare there is no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "WHO. Epilepsy. 2019.  Retrieved from  https://www.who.int/news-room/fact-sheets/detail/epilepsy."}, {"Citation": "Beghi E., Giussani G., Nichols E., et al. Global, regional, and national burden of epilepsy, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology. 2019;18(4):357\u2013375. doi: 10.1016/S1474-4422(18)30454-X.", "ArticleIdList": ["10.1016/S1474-4422(18)30454-X", "PMC6416168", "30773428"]}, {"Citation": "Naimo G. D., Guarnaccia M., Sprovieri T., et al. A systems biology approach for personalized medicine in refractory epilepsy. International Journal of Molecular Sciences. 2019;20(15):p. 3717. doi: 10.3390/ijms20153717.", "ArticleIdList": ["10.3390/ijms20153717", "PMC6695675", "31366017"]}, {"Citation": "Clossen B. L., Reddy D. S. Novel therapeutic approaches for disease-modification of epileptogenesis for curing epilepsy. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 2017;1863(6):1519\u20131538. doi: 10.1016/j.bbadis.2017.02.003.", "ArticleIdList": ["10.1016/j.bbadis.2017.02.003", "PMC5474195", "28179120"]}, {"Citation": "Choudhury P. R., Talukdar A. D., Nath D., Saha P., Nath R. Traditional Folk Medicine and Drug Discovery: prospects and outcome. Advances in Pharmaceutical Biotechnology: Recent Progress and Future Applications. 2020;3 doi: 10.1007/978-981-15-2195-9_1.", "ArticleIdList": ["10.1007/978-981-15-2195-9_1"]}, {"Citation": "Mante P. K., Adongo D. W., Woode E., Kukuia K. K. E., Ameyaw E. O. Anticonvulsant effect of Antiaris toxicaria (Pers.) Lesch. (Moraceae) aqueous extract in rodents. International Scholarly Research Notices: Pharmacology. 2013;2013", "ArticleIdList": ["PMC3791639", "24167736"]}, {"Citation": "Adongo D. W., Mante P. K., Woode E., Ameyaw E. O., Kukuia K. K. E. Effects of hydroethanolic leaf extract of Pseudospondias microcarpa (A. Rich.) Engl. (Anacardiaceae) on the central nervous system in mice: the role of excitatory/inhibitory neurotransmission and nitric oxide pathway. Journal of Ethnopharmacology. 2014;206:78\u201391.", "ArticleIdList": ["28528187"]}, {"Citation": "Kukuia K. K. E., Ameyaw E. O., Woode E., Mante P. K., Adongo D. W. Enhancement of inhibitory neurotransmission and inhibition of excitatory mechanisms underlie the anticonvulsant effects of Mallotus oppositifolius. Journal of Pharmacy & Bioallied Sciences. 2016;8(3):253\u2013261. doi: 10.4103/0975-7406.183226.", "ArticleIdList": ["10.4103/0975-7406.183226", "PMC4929967", "27413356"]}, {"Citation": "Nsagha D. S., Ayima C. W., Nana-Njamen T., Assob J. C. N. The role of traditional, complementary/alternative medicine in primary healthcare, adjunct to universal health coverage in Cameroon: a review of the literature. American Journal of Epidemiology. 2020;8(1):37\u201347."}, {"Citation": "Amtul Z. Studies in Natural Products Chemistry. Vol. 56. Elsevier; 2018. Nature's medicines to treat epileptic seizures; pp. 129\u2013150."}, {"Citation": "Kinda P. T., Zerbo P., Guenn\u00e9 S., Compaor\u00e9 M., Ciobica A., Kiendrebeogo M. Medicinal plants used for neuropsychiatric disorders treatment in the Hauts Bassins region of Burkina Faso. Medicine. 2017;4(2):p. 32.", "ArticleIdList": ["PMC5590068", "28930246"]}, {"Citation": "Obese E., Ameyaw E. O., Biney R. P., Henneh I. T., Edzeamey F. J., Woode E. Phytochemical screening and anti-inflammatory properties of the hydroethanolic leaf extract of Calotropis procera (Ait). R. Br. (Apocynaceae) Journal of Pharmaceutical Research International. 2018;23(1):1\u201311. doi: 10.9734/JPRI/2018/42529.", "ArticleIdList": ["10.9734/JPRI/2018/42529"]}, {"Citation": "Vezzani A., Fujinami R. S., White H. S., et al. Infections, inflammation and epilepsy. Acta Neuropathologica. 2016;131(2):211\u2013234. doi: 10.1007/s00401-015-1481-5.", "ArticleIdList": ["10.1007/s00401-015-1481-5", "PMC4867498", "26423537"]}, {"Citation": "Hawry\u0142 A., Hawry\u0142 M., Waksmundzka-Hajnos M. Liquid chromatography fingerprint analysis and antioxidant activity of selected lavender species with chemometric calculations. PloS one. 2019;14(7) doi: 10.1371/journal.pone.0218974.", "ArticleIdList": ["10.1371/journal.pone.0218974", "PMC6615620", "31287826"]}, {"Citation": "Richa K. H., Shikha S. Phytochemical investigations and anatomical study of two species of Calotropis from Chandigarh. International Journal of Pharmaceutical Sciences and Research. 2015;6(4)"}, {"Citation": "Obese E., Biney R. P., Henneh I. T., et al. Antinociceptive effect of the hydroethanolic leaf extract of Calotropis procera (Ait) R. Br. (Apocynaceae): Possible involvement of glutamatergic, cytokines, opioidergic and adenosinergic pathways. Journal of Ethnopharmacology. 2021;278:p. 114261. doi: 10.1016/j.jep.2021.114261.", "ArticleIdList": ["10.1016/j.jep.2021.114261", "34111540"]}, {"Citation": "Bogdanov N. N., Poletaeva I. I., Popova N. V. Pentylenetetrazol and strychnine convulsions in brain weight selected mice. Seizure. 1997;6(2):135\u2013138. doi: 10.1016/S1059-1311(97)80067-2.", "ArticleIdList": ["10.1016/S1059-1311(97)80067-2", "9153726"]}, {"Citation": "Turski L., Ikonomidou C., Turski W. A., Bortolotto Z. A., Cavalheiro E. A. Review: cholinergic mechanisms and epileptogenesis. The seizures induced by pilocarpine: a novel experimental model of intractable epilepsy. Synapse. 1989;3(2):154\u2013171. doi: 10.1002/syn.890030207.", "ArticleIdList": ["10.1002/syn.890030207", "2648633"]}, {"Citation": "Asehinde S., Ajayi A., Bakre A., Omorogbe O., Adebesin A., Umukoro S. Effects of Jobelyn\u00ae on isoniazid-induced seizures, biomarkers of oxidative stress and glutamate decarboxylase activity in mice. Basic and clinical neuroscience. 2018;9(6):389\u2013396. doi: 10.32598/bcn.9.6.389.", "ArticleIdList": ["10.32598/bcn.9.6.389", "PMC6359684", "30719253"]}, {"Citation": "Shams G., Ismail H. F., Chee T. L., et al. Development of HPLC fingerprint analysis of traditional diabetes herbal Jamu diabetes plant materials. Jurnal Teknologi. 2014;68(1) doi: 10.11113/jt.v68.1686.", "ArticleIdList": ["10.11113/jt.v68.1686"]}, {"Citation": "Webb T. I., Lynch J. W. Molecular pharmacology of the glycine receptor chloride channel. Current Pharmaceutical Design. 2007;13(23):2350\u20132367. doi: 10.2174/138161207781368693.", "ArticleIdList": ["10.2174/138161207781368693", "17692006"]}, {"Citation": "Sheardown M. J., Drejer J., Jensen L. H., Stidsen C. E., Honor\u00e9 T. A potent antagonist of the strychnine insensitive glycine receptor has anticonvulsant properties. European Journal of Pharmacology. 1989;174(2-3):197\u2013204. doi: 10.1016/0014-2999(89)90312-9.", "ArticleIdList": ["10.1016/0014-2999(89)90312-9", "2560979"]}, {"Citation": "Sadek B., Oz M., Nurulain S. M., et al. Phenylalanine derivatives with modulating effects on human \u03b11-glycine receptors and anticonvulsant activity in strychnine-induced seizure model in male adult rats. Epilepsy Research. 2017;138:124\u2013131. doi: 10.1016/j.eplepsyres.2017.05.008.", "ArticleIdList": ["10.1016/j.eplepsyres.2017.05.008", "28554717"]}, {"Citation": "Wang L. F., Zhao M. L., Liu Y. Experimental pharmacodynamic study on the anti-convulsion effect of shenpu decoction. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2001;21(11):837\u2013839.", "ArticleIdList": ["12575379"]}, {"Citation": "Eglen R. M., Choppin A., Watson N. Therapeutic opportunities from muscarinic receptor research. Trends in Pharmacological Sciences. 2001;22(8):409\u2013414. doi: 10.1016/S0165-6147(00)01737-5.", "ArticleIdList": ["10.1016/S0165-6147(00)01737-5", "11479003"]}, {"Citation": "Mirza N. R., Peters D., Sparks R. G. Xanomeline and the antipsychotic potential of muscarinic receptor subtype-selective agonists. CNS Drug Reviews. 2003;9(2):159\u2013186. doi: 10.1111/j.1527-3458.2003.tb00247.x.", "ArticleIdList": ["10.1111/j.1527-3458.2003.tb00247.x", "PMC6741650", "12847557"]}, {"Citation": "Wirtshafter D. The selective m1 muscarinic antagonist MT-7 blocks pilocarpine-induced striatal Fos expression. Brain Research. 2006;1085(1):127\u2013131. doi: 10.1016/j.brainres.2006.02.022.", "ArticleIdList": ["10.1016/j.brainres.2006.02.022", "16564505"]}, {"Citation": "Liu Z., Nagao T., Desjardins G. C., Gloor P., Avoli M. Quantitative evaluation of neuronal loss in the dorsal hippocampus in rats with long-term pilocarpine seizures. Epilepsy Research. 1994;17(3):237\u2013247.", "ArticleIdList": ["8013446"]}, {"Citation": "Wall C. J., Kendall E. J., Obenaus A. Rapid alterations in diffusion-weighted images with anatomic correlates in a rodent model of status epilepticus. American Journal of Neuroradiology. 2000;21(10):1841\u20131852.", "ArticleIdList": ["PMC7974296", "11110536"]}, {"Citation": "Szyndler J., Wierzba-Bobrowicz T., Skorzewska A., et al. Behavioral, biochemical and histological studies in a model of pilocarpine- induced spontaneous recurrent seizures. Pharmacology Biochemistry and Behavior. 2005;81(1):15\u201323. doi: 10.1016/j.pbb.2005.01.020.", "ArticleIdList": ["10.1016/j.pbb.2005.01.020", "15894059"]}, {"Citation": "Perez-Mendes P., Blanco M. M., Calcagnotto M. E., et al. Modeling epileptogenesis and temporal lobe epilepsy in a non-human primate. Epilepsy Research. 2011;96(1-2):45\u201357. doi: 10.1016/j.eplepsyres.2011.04.015.", "ArticleIdList": ["10.1016/j.eplepsyres.2011.04.015", "21620680"]}, {"Citation": "Chen H.-C., Kodell R. L., Cheng K. F., Chen J. J. Assessment of performance of survival prediction models for cancer prognosis. BMC Medical Research Methodology. 2012;12(1) doi: 10.1186/1471-2288-12-102.", "ArticleIdList": ["10.1186/1471-2288-12-102", "PMC3410808", "22824262"]}, {"Citation": "Bassin S., Smith T. L., Bleck T. P. Clinical review: status epilepticus. Critical Care. 2002;6(2):137\u2013142. doi: 10.1186/cc1472.", "ArticleIdList": ["10.1186/cc1472", "PMC137295", "11983039"]}, {"Citation": "Bronstein A. C., Spyker D. A., Cantilena L. R., Green J. L., Rumack B. H., Dart R. C. Annual report of the American Association of Poison Control Centers\u2019 National Poison Data System (NPDS): 28th annual report. Clinical Toxicology. 2010;49:910\u2013941.", "ArticleIdList": ["22165864"]}, {"Citation": "Corda M. G., Costa E., Guidotti A. Specific proconvulsant action of an imidazobenzodiazepine (Ro 15-1788) on isoniazid convulsions. Neuropharmacology. 1982;21(1):91\u201394. doi: 10.1016/0028-3908(82)90217-9.", "ArticleIdList": ["10.1016/0028-3908(82)90217-9", "6278356"]}, {"Citation": "Cevik M. U., Acar A., Tanriverdi H., et al. Toxic effects of isoniazid and rifampicin on rat brain tissue: the preventive role of caffeic acid phenethyl ester. International Journal of Pharmacology. 2012;8(6):555\u2013560. doi: 10.3923/ijp.2012.555.560.", "ArticleIdList": ["10.3923/ijp.2012.555.560"]}, {"Citation": "Minns A. B., Ghafouri N., Clark R. F. Isoniazid-induced status epilepticus in a pediatric patient after inadequate pyridoxine therapy. Pediatric Emergency Care. 2010;26(5):380\u2013381. doi: 10.1097/PEC.0b013e3181db24b6.", "ArticleIdList": ["10.1097/PEC.0b013e3181db24b6", "20453796"]}, {"Citation": "Kendall D. A., Fox D. A., Enna S. J. Effect of \u03b3-vinyl GABA on bicuculline-induced seizures. Neuropharmacology. 1981;20(4):351\u2013355. doi: 10.1016/0028-3908(81)90008-3.", "ArticleIdList": ["10.1016/0028-3908(81)90008-3", "7290349"]}, {"Citation": "Olsen R. W. GABA-benzodiazepine-barbiturate receptor interactions. Journal of Neurochemistry. 1981;37(1):1\u201313. doi: 10.1111/j.1471-4159.1981.tb05284.x.", "ArticleIdList": ["10.1111/j.1471-4159.1981.tb05284.x", "6265597"]}, {"Citation": "Nicoll R. A. Introduction to the pharmacology of CNS drugs. In: Katzung B. G., editor. Basic and Clinical Pharmacology. 8th. New York: Lange Medical Books/McGraw-Hill; 2001."}, {"Citation": "Vel\u00ed\u0161ek L. Models of Seizures and Epilepsy. Academic Press; 2006."}, {"Citation": "Kumar V. Potential medicinal plants for CNS disorders: an overview. Phytotherapy Research. 2006;20(12):1023\u20131035. doi: 10.1002/ptr.1970.", "ArticleIdList": ["10.1002/ptr.1970", "16909441"]}, {"Citation": "Macdermott A. B., Role L. W., Siegelbaum S. A. Presynaptic ionotropic receptors and the control of transmitter release. Annual Review of Neuroscience. 1999;22(1):443\u2013485. doi: 10.1146/annurev.neuro.22.1.443.", "ArticleIdList": ["10.1146/annurev.neuro.22.1.443", "10202545"]}, {"Citation": "L\u00f6scher W. Animal models of epilepsy for the development of anti-epileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Research. 2002;50(1-2):105\u2013123. doi: 10.1016/S0920-1211(02)00073-6.", "ArticleIdList": ["10.1016/S0920-1211(02)00073-6", "12151122"]}, {"Citation": "Przegalinski E., Tatarczynska E., Chojnacka-Wojcik E. The influence of the benzodiazepine receptor antagonist flumazenil on the anxiolytic-like effects of CGP 37849 and ACPC in rats. Neuropharmacology. 2000;39(10):1858\u20131864. doi: 10.1016/S0028-3908(00)00023-X.", "ArticleIdList": ["10.1016/S0028-3908(00)00023-X", "10884566"]}, {"Citation": "Ramachandra V., Shenoy S., Madhyastha M., Desai R., Ghosh S. Evaluation of effect of aqueous extract of leaves of Calotropis procera in pentylenetetrazole induced seizures in rats. International Journal of Basic & Clinical Pharmacology. 2016;5(3):643\u2013646. doi: 10.18203/2319-2003.ijbcp20161484.", "ArticleIdList": ["10.18203/2319-2003.ijbcp20161484"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "2", "Day": "16"}, {"Year": "2021", "Month": "5", "Day": "31"}, {"Year": "2021", "Month": "6", "Day": "19"}, {"Year": "2021", "Month": "7", "Day": "14", "Hour": "7", "Minute": "2"}, {"Year": "2021", "Month": "7", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "1", "Day": "19", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "6", "Day": "26"}], "PublicationStatus": "epublish", "ArticleIdList": ["34257639", "PMC8257368", "10.1155/2021/5566890"]}}], "PubmedBookArticle": []}